CINECA IRIS Institutional Research Information System

CASALE, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.634
EU - Europa 2.242
AS - Asia 886
SA - Sud America 67
AF - Africa 16
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.516
IT - Italia 643
CN - Cina 363
SE - Svezia 255
IE - Irlanda 223
DE - Germania 222
SG - Singapore 219
AT - Austria 168
FR - Francia 147
UA - Ucraina 133
FI - Finlandia 130
CA - Canada 100
GB - Regno Unito 95
ES - Italia 74
KR - Corea 66
IN - India 48
PL - Polonia 46
TR - Turchia 46
BR - Brasile 42
JP - Giappone 41
VN - Vietnam 39
BE - Belgio 21
ID - Indonesia 20
NL - Olanda 19
MX - Messico 16
CL - Cile 12
HK - Hong Kong 11
SN - Senegal 11
AU - Australia 10
CH - Svizzera 10
RU - Federazione Russa 10
HR - Croazia 9
CZ - Repubblica Ceca 8
UZ - Uzbekistan 8
TW - Taiwan 7
CO - Colombia 6
GR - Grecia 6
AR - Argentina 5
PT - Portogallo 5
LB - Libano 4
RO - Romania 4
RS - Serbia 4
EU - Europa 3
IR - Iran 3
NO - Norvegia 3
BG - Bulgaria 2
DK - Danimarca 2
IS - Islanda 2
KZ - Kazakistan 2
MU - Mauritius 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CI - Costa d'Avorio 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TT - Trinidad e Tobago 1
Totale 5.860
Salva come PNG Salva come JPEG
Città #
Chandler 351
Dublin 222
Torino 213
Beijing 204
Singapore 185
Vienna 165
Fairfield 121
Ashburn 119
Ann Arbor 118
Jacksonville 104
Houston 95
Villeurbanne 85
Nyköping 80
Redwood City 74
Medford 66
Santa Clara 63
Columbus 58
Princeton 57
Dearborn 56
Turin 49
Wilmington 47
Woodbridge 47
Warsaw 44
Fremont 39
Cambridge 38
Pisa 36
Milan 35
Seattle 32
Rome 30
Toronto 30
Dong Ket 24
Lappeenranta 24
Brussels 20
Boardman 19
Jakarta 18
Sanayi 18
New York 17
Guangzhou 15
London 14
Boston 13
Bochum 12
Helsinki 12
Munich 12
Nürnberg 12
San Diego 12
Waterloo 12
Falls Church 11
Nanjing 10
Amsterdam 9
Pune 9
Tokyo 9
Zhengzhou 9
Chengdu 8
Hefei 8
San Mauro Torinese 8
São Paulo 8
Verona 8
Bologna 7
Mountain View 7
Norwalk 7
Washington 7
Xian 7
Ankara 6
Chicago 6
Genova 6
Ottawa 6
Palermo 6
Greenwood 5
Hangzhou 5
Hong Kong 5
Madrid 5
Modena 5
Mumbai 5
Santiago 5
Shanghai 5
São Luís de Montes Belos 5
Antofagasta 4
Berlin 4
Cagliari 4
Changsha 4
Detroit 4
Dronten 4
Istanbul 4
Kunming 4
Lachine 4
Leawood 4
Los Angeles 4
Mulhouse 4
Nanchang 4
Orillia 4
Oxford 4
Québec 4
Salerno 4
Shenyang 4
Taipei 4
Tokushima 4
Willowdale 4
Baltimore 3
Beaconsfield 3
Beirut 3
Totale 3.417
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis and food intake 756
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy 327
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 238
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 186
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 173
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 157
NOX2 in the hSOD1G93A Transgenic Swine: a preliminary overview 155
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 151
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 139
A Strange Loop: Effects of emotional facial expressions impaired recognition in ALS Patients and in their Caregivers. 135
Expression of NOX2 protein in neutrophils of patients with ALS 124
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detection: validation and application in pharmacokinetic study 113
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 113
NADPH Oxidases (NOX) Enzymes Induced Oxidative Stress in CIDP Patients 109
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients 107
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 107
HFE p.H63D polymorphism does not influence ALS phenotype and survival 104
Monitoring of Submicron Particulate Matter Concentrationsin the Air of Turin City, Italy. Influence of Traffic-limitations 100
Plasma Erythropoietin levels in patients receiving intensive platinum or non-platinum chemotherapy 98
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 96
Pharmacokinetics and tolerability profile of three new formulations of disodium clodronate after single intramuscular injection in healthy volunteers 94
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 93
NADPH oxidases (NOX) enzymes induced oxidative stress in CIDP patients 93
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 92
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 91
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data 85
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 85
NADPH oxidases 2 activation in patients with Parkinson's disease 85
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients 85
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 81
Simultaneous HPLC determination of 5-Fluorouracil and its metabolites in plasma of cancer patients 79
Plasma immunoerythropoietin levels in patients with cancer receiving platin-based or 5-Fluorouracil-based chemotherapy 75
Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants 74
Cholinergic modulation of Early Growth Response Factor (Egr-1) expression on human neuroblastoma Sk-N-BE cells 74
PPAR gamma ligands and 4-hydroxinonenal affect growth, differentiation and apotosis in human caco-2 cells 72
Changes of rat hippocampal egr-1 expression during the acquisition and retrieval memory phases 71
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 71
Single dose intramuscolar pharmacokinetics and local tolerability of three different disodium clodronate formulations in healthy volunteers 70
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 69
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 68
Pharmacokinetics of Cyclosporine microemulsion in recipients of marginal versus normal liver transplants 67
Plasma concentrations of 5-Fluorouracil and its metabolites in colon cancer patients 67
Indipendent drug information: the SIF Farmaci in evidenza input 63
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 62
SIF farmaci in evidenza 58
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 58
SIF Farmaci in evidenza 52
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 45
SIF-Farmaci in evidenza 42
SIF-Farmaci in evidenza: una nuova iniziativa della Società Italiana di Farmacologia 39
SIF- Farmaci in evidenza 39
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 38
Tossicità Polmonare 38
Social Cognition deficits in Amyotrophic Lateral Sclerosis: a pilot cross-sectional population-based study 38
SIF-Farmaci in evidenza 37
SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients 33
Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis 29
Systematic evaluation of genetic mutations in ALS: a population-based study 26
SIF Farmaci in evidenza 26
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis 23
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis 18
The role of peripheral immunity in ALS: a population-based study 17
Mycotoxins and Amyotrophic Lateral Sclerosis: food exposure, nutritional implications and dietary solutions 13
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells 13
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis 10
Totale 6.046
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.957
article - articoli 0
book - libri 0
conference - conferenze 5.492
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020527 0 0 0 0 30 109 79 30 82 102 47 48
2020/2021690 69 39 48 43 74 43 49 29 116 62 46 72
2021/2022832 24 18 37 65 51 82 40 36 44 111 194 130
2022/20231.090 132 85 28 102 110 271 80 57 109 44 42 30
2023/2024643 82 104 50 31 45 75 43 44 9 49 40 71
2024/2025500 27 92 60 117 204 0 0 0 0 0 0 0
Totale 6.046